FDA Inspection
Libby Laboratories, Inc.Libby Laboratories, Inc. – FDA Inspection, Mar 14, 2025
Record Details
This FDA Inspection record concerns Libby Laboratories, Inc., with an inspection on March 14, 2025, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · 51a7e34a-e34f-4843-947f-500c5cc2476f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1263751
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.165(b)Microbiological testing
- 21 CFR 211.84(a)Components withheld from use pending release
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Libby Laboratories, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 8, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 6, 2015 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| January 18, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 3, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 11, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Libby Laboratories, Inc.
- FDA Inspection 1112955 - 2019-11-08
- FDA Inspection 942277 - 2015-08-06
- FDA Inspection 762766 - 2012-01-18
- FDA Inspection 659890 - 2010-05-03
- FDA Inspection 599092 - 2009-06-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.